New injection aims to melt away double chin fat
NCT ID NCT06756490
Summary
This is an early-stage study testing the safety of a new injectable drug, HY-2003, for reducing fat under the chin (a double chin). The study will enroll 30 adults with moderate to severe chin fullness to see how safe the drug is at different doses and how the body processes it. Researchers will compare the new injection to a placebo and an existing treatment to gather initial data.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE OR SEVERE SUBMENTAL FULLNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact Email: •••••@•••••
-
The First Affiliated Hospital of Xi'an Jiaotong University
RECRUITINGXi'an, Shaanxi, 710061, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.